Several studies reported that reactive oxygen species (ROS) participate in the activation of NF-κB, a key player in tumorigenesis, and that excess ROS produced by cancer cells trigger tumor invasion and angiogenesis via NF-κB-mediated MMP-9 activation [10], [11]. Here, NFKB1 is linked to cancer.